Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in Pregnancy
NCT02129465 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2018-01-03
Summary
Analysis of several characteristics of blood from pregnant women with CMV infection according to maternal-fetal transmission. These include CMV viral load, cytokine profile in response to in-vitro stimulation with CMV peptides, meticulous analysis of anti CMV antibodies, maternal DNA polymorphism and microarray of gene expression.
Conditions
- Pregnancy
- Cytomegalovirus Infections
- Congenital Infection
Sponsors & Collaborators
-
Shaare Zedek Medical Center
lead OTHER
Principal Investigators
-
Yechiel Schlesinger, MD · Shaare Zedek Medical Center, Jerusalem, Israel
-
Yifat Eldar-Yedidia, Ph.D. · Shaare Zedek Medical Center, Jerusalem, Israel
Eligibility
- Min Age
- 18 Years
- Max Age
- 42 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2018-12-31
- Completion
- 2019-05-31
Countries
- Israel
Study Locations
More Related Trials
-
Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection
NCT01659684 ·Status: UNKNOWN ·Phase: NA
-
Cytomegalovirus (CMV) Infection in Amniotic Fluid
NCT00194142 ·Status: COMPLETED
-
Does Normal Brain Imaging Predict Normal Neurodevelopmental Outcome in Fetuses With Proven Cytomegalovirus Infection?
NCT00872703 ·Status: COMPLETED
-
Assessment of Post-traumatic Stress Disorder (PTSD) in Patients Monitored for Cytomegalovirus (CMV) Seroconversion During Pregnancy,
NCT04658810 ·Status: COMPLETED
-
A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Newborns in China
NCT02645396 ·Status: COMPLETED
-
Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)
NCT05170269 ·Status: TERMINATED ·Phase: PHASE3
-
Transfusion-Transmitted Cytomegalovirus Prevention in Neonates
NCT00000584 ·Status: COMPLETED ·Phase: PHASE3
-
Screening for Congenital Cytomegalovirus Infection in Newborns
NCT02683096 ·Status: COMPLETED
-
Evaluation of a Serology Diagnostic Kit for the Detection of Genital Mycoplasma in Pregnancy
NCT01281319 ·Status: UNKNOWN
-
Diagnosis of Congenital Cytomegalovirus Infection in Newborn With Particular Risk
NCT05754879 ·Status: COMPLETED
-
Non Primary HCMV Infection: Natural History and Immune Response
NCT06337955 ·Status: ACTIVE_NOT_RECRUITING
-
Epidemiology and Prevention of Congenital HCMV in Immune Mothers. Congenital HCMV Infection Lombardy
NCT03973359 ·Status: UNKNOWN ·Phase: NA
-
Prenatal Behavioral Intervention to Prevent Maternal Cytomegalovirus (CMV) in Pregnancy
NCT04615715 ·Status: COMPLETED ·Phase: NA
-
Detection of Human Cytomegalovirus in the Saliva
NCT00815802 ·Status: COMPLETED
-
TT-CMV Observational Birth Cohort Study
NCT00907686 ·Status: COMPLETED
-
Epidemiology of Human Cytomegalovirus Excretion in the Saliva of Children Attending Nursery in France
NCT01704222 ·Status: COMPLETED
-
Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening
NCT02139423 ·Status: COMPLETED ·Phase: NA
-
Cytomegalovirus (CMV) Transmission by Frozen Breast Milk in Preterms
NCT00668798 ·Status: SUSPENDED
-
Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients
NCT00467532 ·Status: COMPLETED
-
Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero
NCT01923636 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of Behavioral Modification to Prevent Congenital Cytomegalovirus
NCT01819519 ·Status: COMPLETED ·Phase: NA
-
Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection
NCT04934527 ·Status: COMPLETED ·Phase: PHASE2
-
Cytomegalovirus Shedding Characteristics in Pregnant Women
NCT04021628 ·Status: COMPLETED
-
Investigation of the Passage of Antiviral Antibodies From Mother to Child
NCT05821764 ·Status: UNKNOWN
-
Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants
NCT01178905 ·Status: COMPLETED ·Phase: NA